Cutting-edge mRNA technology brought safe, effective COVID-19 vaccines to a world in crisis — could it do the same for a much older foe, HIV?
An experimental HIV vaccine that uses the same mRNA platform technology as the Pfizer and Moderna COVID-19 vaccines shows promise in animals, a new U.S. government-led study finds.
“Despite nearly four decades of effort by the global research community, an effective vaccine to prevent HIV remains an elusive goal,” said Dr. Anthony Fauci. Besides being the nation’s leading adviser on infectious disease, he also directs the U.S. National Institute of Allergy and Infectious Diseases (NIAID), where the new research was conducted.
